BackInVivo Therapeutics Holdings Overview

InVivo Therapeutics Holdings Other Current Assets

InVivo Therapeutics Holdings's other current assets is $320K.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$321000.00
53.21% YoYΔ $-365000.00 vs prior year quarter

Peer average / median

Loading

InVivo Therapeutics Holdings Other Current Assets History

Loading

InVivo Therapeutics Holdings vs. peers: Other Current Assets Comparison

Loading

InVivo Therapeutics Holdings Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

InVivo Therapeutics Holdings (NVIV) FAQ

InVivo Therapeutics Holdings (NVIV) currently reports a other current assets of $320K as of September 2023. That compares with $690K in the prior-year period — down 53.2% year over year. Use the charts on this page to explore InVivo Therapeutics Holdings's other current assets history and peer comparisons.

InVivo Therapeutics Holdings's other current assets decreased from $690K to $320K — a 53.2% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

InVivo Therapeutics Holdings reported $320K in other current assets as of September 2023. That compares with $690K in the prior-year period — down 53.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $320K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for InVivo Therapeutics Holdings, and consider following NVIV for alerts when major investors trade the stock.

InVivo Therapeutics Holdings is classified in the Healthcare sector. On other current assets, it currently shows $320K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NVIV with unrelated industries.